Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Info |  Desc |  Directly Accessed By Routines |  Accessed By FileMan Db Calls |  Pointed To By FileMan Files |  Pointer To FileMan Files |  Fields |  Found Entries |  External References |  Global Variables Directly Accessed |  Local Variables  | All
Print Page as PDF
Global: ^ONCO(169.3

Package: Oncology

Global: ^ONCO(169.3


Information

FileMan FileNo FileMan Filename Package
169.3 ICD-O-3 MORPHOLOGY Oncology

Description

Directly Accessed By Routines, Total: 21

Package Total Routines
Oncology 21 ONC2PR13    ONC2PR14    ONC2PR17    ONC2PR18    ONC2PS01    ONC2PS04    ONC2PS09    ONCOAI
ONCOHICD    ONCOXNC    ONCOXU    ONCSSF2    ONCSSF3    ONCSSF4    ONCSSF5    ^ONCO(169.3
ONCSSF6    ^ONCO(169.99    ONCSSF1    ONCUPLPR    SYNONYM/EQUIVALENT TERM    

Accessed By FileMan Db Calls, Total: 3

Package Total Routines
Oncology 3 ONC2PS01    ONC2PS04    ONC2PS09    

Pointed To By FileMan Files, Total: 2

Package Total FileMan Files
Oncology 2 SITE-GROUP FOR ONCOLOGY(#164.2)[#164.23(.01)]    ONCOLOGY PRIMARY(#165.5)[22.3]    

Pointer To FileMan Files, Total: 3

Package Total FileMan Files
Oncology 3 ICDO TOPOGRAPHY(#164)[44.1]    ICDO-SITES(#164.08)[3]    SEER CODE SET(#164.5)[4343.0143.025353.0153.02]    

Fields, Total: 14

Field # Name Loc Type Details
.001 NUMBER NUMBER

  • INPUT TRANSFORM:  K:+X'=X!(X>99999)!(X<80000)!(X?.E1"."1N.N) X
  • LAST EDITED:  NOV 17, 2000
  • HELP-PROMPT:  Type a Number between 80000 and 99999, 0 Decimal Digits
.01 NAME 0;1 FREE TEXT
************************REQUIRED FIELD************************

  • INPUT TRANSFORM:  K:$L(X)>80!($L(X)<2)!'(X'?1P.E) X
  • LAST EDITED:  OCT 29, 2009
  • HELP-PROMPT:  Answer must be 2-80 characters in length.
  • DESCRIPTION:  
    Identifies the ICD-O (International Classification of Diseases for Oncology (Third Edition)) terms.
  • CROSS-REFERENCE:  169.3^B
    1)= S ^ONCO(169.3,"B",$E(X,1,30),DA)=""
    2)= K ^ONCO(169.3,"B",$E(X,1,30),DA)
1 CODE 0;2 FREE TEXT

  • INPUT TRANSFORM:  K:$L(X)>6!($L(X)<3) X
  • LAST EDITED:  NOV 20, 2000
  • HELP-PROMPT:  Answer must be 3-6 characters in length.
  • CROSS-REFERENCE:  169.3^D
    1)= S ^ONCO(169.3,"D",$E(X,1,30),DA)=""
    2)= K ^ONCO(169.3,"D",$E(X,1,30),DA)
    Indexes file by CODE.
2 SYNONYM/EQUIVALENT TERM 1;0 Multiple #169.32 169.32

  • LAST EDITED:  JAN 31, 2001
  • DESCRIPTION:  This field contains the synonyms and equivalent terms for this morphology.
3 ICDO-SITE 0;5 POINTER TO ICDO-SITES FILE (#164.08) ICDO-SITES(#164.08)

  • LAST EDITED:  NOV 20, 2000
  • DESCRIPTION:  
    POINTS TO THE ICDO SITE FILE.
4 TOPOGRAPHY 1 0;6 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • LAST EDITED:  JAN 31, 2001
  • DESCRIPTION:  This field indicates a usual primary site (ICD-O TOPOGRPAHY) for this morphology.
  • CROSS-REFERENCE:  169.3^AC
    1)= S ^ONCO(169.3,"AC",$E(X,1,4),DA)=""
    2)= K ^ONCO(169.3,"AC",$E(X,1,4),DA)
4.1 TOPOGRAPHY 2 0;3 POINTER TO ICDO TOPOGRAPHY FILE (#164) ICDO TOPOGRAPHY(#164)

  • LAST EDITED:  JAN 31, 2001
  • DESCRIPTION:  This field indicates a usual primary site (ICD-O TOPOGRPAHY) for this morphology.
  • CROSS-REFERENCE:  169.3^AC
    1)= S ^ONCO(169.3,"AC",$E(X,1,4),DA)=""
    2)= K ^ONCO(169.3,"AC",$E(X,1,4),DA)
43 EXTENSION CODE SET-1ST ED E;1 POINTER TO SEER CODE SET FILE (#164.5) SEER CODE SET(#164.5)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  APR 06, 2001
  • DESCRIPTION:  
    This field identifies the set of codes used to characterize extension for this topography in the first edition of SEER Extent of Disease Codes and Coding Instructions.
  • SCREEN:  S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>1"
  • EXPLANATION:  A first edition extension code set may be selected.
43.01 EXTENSION CODE SET-2ND ED E;2 POINTER TO SEER CODE SET FILE (#164.5) SEER CODE SET(#164.5)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  NOV 20, 2000
  • DESCRIPTION:  
    This field identifies the set of codes used to characterize extension for this topography in the second edition of SEER Extent of Disease Codes and Coding Instructions.
  • SCREEN:  S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>2"
  • EXPLANATION:  A first or second edition extension code set may be selected.
43.02 EXTENSION CODE SET-3RD ED E;3 POINTER TO SEER CODE SET FILE (#164.5) SEER CODE SET(#164.5)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>3" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  NOV 20, 2000
  • DESCRIPTION:  
    This field identifies the set of codes used to characterize extension for this topography in the third edition of SEER Extent of Disease Codes and Coding Instructions.
  • SCREEN:  S DIC("S")="I $P(^(0),U,5)=""E"",$P(^(0),U,2)'>3"
  • EXPLANATION:  A first, second or third edition extension code set may be selected.
53 LYMPH NODE CODE SET-1ST ED L;1 POINTER TO SEER CODE SET FILE (#164.5) SEER CODE SET(#164.5)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  NOV 20, 2000
  • DESCRIPTION:  
    This field identifies the set of codes used to characterize lymph node involvement for this topography in the first edition of SEER Extent of Disease Codes and Coding Instructions.
  • SCREEN:  S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>1"
  • EXPLANATION:  A first edition lymph node code set may be selected.
53.01 LYMPH NODE CODE SET-2ND ED L;2 POINTER TO SEER CODE SET FILE (#164.5) SEER CODE SET(#164.5)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  NOV 20, 2000
  • DESCRIPTION:  
    This field identifies the set of codes used to characterize lymph node involvement for this topography in the second edition of SEER Extent of Disease Codes and Coding Instructions.
  • SCREEN:  S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>2"
  • EXPLANATION:  A first or second edition lymph node code set may be selected.
53.02 LYMPH NODE CODE SET-3RD ED L;3 POINTER TO SEER CODE SET FILE (#164.5) SEER CODE SET(#164.5)

  • INPUT TRANSFORM:  S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>3" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X
  • LAST EDITED:  NOV 20, 2000
  • DESCRIPTION:  
    This field identifies the set of codes used to characterize lymph node involvement for this topography in the third edition of SEER Extent of Disease Codes and Coding Instructions.
  • SCREEN:  S DIC("S")="I $P(^(0),U,5)=""L"",$P(^(0),U,2)'>3"
  • EXPLANATION:  A first, second or third edition lymph node code set may be selected.
71 HISTOPATHOLOGIC TYPE 0;8 SET
  • '1' FOR Lymphoid;
  • '2' FOR Embryonal;
  • '3' FOR Epithelial;
  • '4' FOR Reticuloendothelial;
  • '5' FOR Sarcoma;
  • '6' FOR Hematogenous;
  • '7' FOR Melanoma;
  • '8' FOR Nerve;
  • '9' FOR Other;

  • LAST EDITED:  NOV 20, 2000
  • DESCRIPTION:  
    The HISTOPATHOLOGIC TYPE is the category (type) of morphology according to cell type.

Found Entries, Total: 1642

NAME: CYST, EMBRYONIC    NAME: CYST, NEUROGLIAL-LINED    NAME: CYST, EPITHELIAL INCLUSION    NAME: CYST, COLLOID    NAME: SUSPICIOUS FOR MALIGNANT CELLS    NAME: HAMARTOMA    NAME: NEOPLASM, BENIGN    NAME: NEOPLASM, UNCERTAIN BENIGN OR MALIGNANT    
NAME: NEOPLASM, IN SITU    NAME: NEOPLASM, MALIGNANT    NAME: TUMOR CELLS, BENIGN    NAME: TUMOR CELLS, UNCERTAIN BENIGN OR MALIGNANT    NAME: TUMOR CELLS IN SITU    NAME: TUMOR CELLS, MALIGNANT    NAME: IN SITU TUMOR, SMALL CELL TYPE    NAME: MALIGNANT TUMOR, SMALL CELL TYPE    
NAME: IN SITU TUMOR, GIANT CELL TYPE    NAME: MALIGNANT TUMOR, GIANT CELL TYPE    NAME: IN SITU TUMOR, SPINDLE CELL TYPE    NAME: MALIGNANT TUMOR, SPINDLE CELL TYPE    NAME: CLEAR CELL TUMOR, NOS    NAME: CLEAR CELL TUMOR IN SITU    NAME: MALIGNANT TUMOR, CLEAR CELL TYPE    NAME: EPITHELIAL TUMOR, BENIGN    
NAME: CARCINOMA IN SITU, NOS    NAME: CARCINOMA, NOS    NAME: EPITHELIOMA, BENIGN    NAME: EPITHELIOMA IN SITU    NAME: EPITHELIOMA, MALIGNANT    NAME: LARGE CELL CARCINOMA IN SITU    NAME: LARGE CELL CARCINOMA, NOS    NAME: LARGE CELL NEUROENDOCRINE CARCINOMA IN SITU    
NAME: LARGE CELL NEUROENDOCRINE CARCINOMA    NAME: LARGE CELL CA WITH RHABDOID PHENOTYPE IN SITU    NAME: LARGE CELL CARCINOMA WITH RHABDOID PHENOTYPE    NAME: GLASSY CELL CARCINOMA IN SITU    NAME: GLASSY CELL CARCINOMA    NAME: CARCINOMA IN SITU, UNDIFFERENTIATED    NAME: CARCINOMA, UNDIFFERENTIATED, NOS    NAME: CARCINOMA IN SITU, ANAPLASTIC    
NAME: CARCINOMA, ANAPLASTIC, NOS    NAME: PLEOMORPHIC CARCINOMA IN SITU    NAME: PLEOMORPHIC CARCINOMA    NAME: NUT CARCINOMA (C30.0, C31.9, C34._)    NAME: GIANT CELL AND SPINDLE CELL CARCINOMA IN SITU    NAME: GIANT CELL AND SPINDLE CELL CARCINOMA    NAME: GIANT CELL CARCINOMA IN SITU    NAME: GIANT CELL CARCINOMA    
NAME: SPINDLE CELL CARCINOMA IN SITU    NAME: SPINDLE CELL CARCINOMA, NOS    NAME: PSEUDOSARCOMATOUS CARCINOMA IN SITU    NAME: PSEUDOSARCOMATOUS CARCINOMA    NAME: POLYGONAL CELL CARCINOMA IN SITU    NAME: POLYGONAL CELL CARCINOMA    NAME: CARCINOMA WITH OSTEOCLAST GIANT CELLS IN SITU    NAME: CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS    
NAME: TUMORLET, BENIGN    NAME: TUMORLET, NOS    NAME: SMALL CELL CARCINOMA IN SITU    NAME: SMALL CELL CARCINOMA, NOS    NAME: OAT CELL CARCINOMA IN SITU    NAME: OAT CELL CARCINOMA    NAME: SMALL CELL CARCINOMA IN SITU, FUSIFORM CELL    NAME: SMALL CELL CARCINOMA, FUSIFORM CELL    
NAME: SMALL CELL CARCINOMA IN SITU, INTERMED CELL    NAME: SMALL CELL CARCINOMA, INTERMEDIATE CELL    NAME: COMBINED SMALL CELL CARCINOMA IN SITU    NAME: COMBINED SMALL CELL CARCINOMA    NAME: NON-SMALL CELL CARCINOMA IN SITU    NAME: NON-SMALL CELL CARCINOMA    NAME: PAPILLOMA, NOS    NAME: PAPILLARY CARCINOMA IN SITU    
NAME: PAPILLARY CARCINOMA, NOS    NAME: VERRUCOUS PAPILLOMA    NAME: VERRUCOUS CARCINOMA IN SITU    NAME: WARTY CARCINOMA    NAME: SQUAMOUS CELL PAPILLOMA, NOS    NAME: PAPILLARY SQUAMOUS CELL CA, NON-INVASIVE    NAME: PAPILLARY SQUAMOUS CELL CARCINOMA    NAME: SQUAMOUS CELL PAPILLOMA, INVERTED    
NAME: WARTY CARCINOMA IN SITU    NAME: CONDYLOMATOUS CARCINOMA (C60.0-C60.2, C60.9)    NAME: SQUAMOUS PAPILLOMATOSIS    NAME: SQUAMOUS CELL CARCINOMA IN SITU, NOS    NAME: SQUAMOUS CELL CARCINOMA, NOS    NAME: SQUAMOUS CELL CA IN SITU, KERATINIZING    NAME: SQUAMOUS CELL CARCINOMA, KERATINIZING, NOS    NAME: SQUAMOUS CA IN SITU/LRG CELL, NONKERATINIZING    
NAME: SQUAMOUS CA, LARGE CELL, NONKERATINIZING, NOS    NAME: SQUAMOUS CA IN SITU/SML CELL, NONKERATINIZING    NAME: SQUAMOUS CELL CA, SMALL CELL, NONKERATINIZING    NAME: SQUAMOUS CELL CA IN SITU, SPINDLE CELL    NAME: SQUAMOUS CELL CARCINOMA, SPINDLE CELL    NAME: SQUAMOUS CELL CA IN SITU, ADENOID    NAME: SQUAMOUS CELL CARCINOMA, ADENOID    NAME: SQUAMOUS CELL CA IN SITU W QUES STROMAL INV    
NAME: SQUAMOUS CELL CARCINOMA, MICROINVASIVE    NAME: SQUAMOUS INTRAEPITHELIAL NEOPLASIA, GRADE III    NAME: SQUAMOUS CELL CA IN SITU WITH HORN FORMATION    NAME: SQUAMOUS CELL CARCINOMA WITH HORN FORMATION    NAME: QUEYRAT ERYTHROPLASIA    NAME: BOWEN DISEASE    NAME: BOWEN DISEASE, MALIGNANT    NAME: LYMPHOEPITHELIAL CARCINOMA IN SITU    
NAME: LYMPHOEPITHELIAL CARCINOMA    NAME: BASALOID SQUAMOUS CELL CARCINOMA IN SITU    NAME: BASALOID SQUAMOUS CELL CARCINOMA    NAME: SQUAMOUS CELL CA IN SITU, CLEAR CELL TYPE    NAME: SQUAMOUS CELL CARCINOMA, CLEAR CELL TYPE    NAME: SCC, HPV-POS (C01.9 C09.9 C10.2 C10.3 C10.8 C10.9 C31.0-C31.3 C31.9)    NAME: SCC, HPV-NEG (C01.9 C09.9 C10.2 C10.3 C10.8 C10.9 C31.0-C31.3 C31.9)    NAME: BASAL CELL TUMOR    
NAME: BASAL CELL CARCINOMA, IN SITU    NAME: BASAL CELL CARCINOMA, NOS    NAME: MULTICENTRIC BASAL CELL CARCINOMA, IN SITU    NAME: MULTIFOCAL SUPERFICIAL BASAL CELL CARCINOMA    NAME: INFILTRATING BASAL CELL CARCINOMA IN SITU    NAME: INFILTRATING BASAL CELL CARCINOMA, NOS    NAME: BASAL CELL CARCINOMA IN SITU, FIBROEPITHELIAL    NAME: BASAL CELL CARCINOMA, FIBROEPITHELIAL    
NAME: BASOSQUAMOUS CARCINOMA IN SITU    NAME: BASOSQUAMOUS CARCINOMA    NAME: METATYPICAL CARCINOMA IN SITU    NAME: METATYPICAL CARCINOMA    NAME: INTRAEPIDERMAL EPITHELIOMA OF JADASSOHN    NAME: BASAL CELL CARCINOMA IN SITU, NODULAR    NAME: BASAL CELL CARCINOMA, NODULAR    NAME: ADENOID BASAL CARCINOMA IN SITU    
NAME: ADENOID BASAL CARCINOMA    NAME: TRICHOEPITHELIOMA    NAME: TRICHOBLASTIC CARCINOMA    NAME: TRICHOFOLLICULOMA    NAME: TRICHOLEMMOMA    NAME: TRICHILEMMOCARCINOMA IN SITU    NAME: TRICHILEMMOCARCINOMA    NAME: PILAR TUMOR    
NAME: PILAR SHEATH ACANTHOMA    NAME: PILOMATRIXOMA, NOS    NAME: PILOMATRIX CARCINOMA IN SITU    NAME: PILOMATRIX CARCINOMA    NAME: TRANSITIONAL CELL PAPILLOMA, BENIGN    NAME: UROTHELIAL PAPILLOMA, NOS    NAME: TRANSITIONAL CELL CARCINOMA IN SITU    NAME: TRANSITIONAL CELL CARCINOMA, NOS    
NAME: SCHNEIDERIAN PAPILLOMA, NOS    NAME: TRANSITIONAL CELL PAPILLOMA, INVERTED, NOS    NAME: SCHNEIDERIAN CARCINOMA IN SITU    NAME: SCHNEIDERIAN CARCINOMA    NAME: TRANSITIONAL CELL CA IN SITU, SPINDLE CELL    NAME: TRANSITIONAL CELL CARCINOMA, SPINDLE CELL    NAME: BASALOID CARCINOMA IN SITU    NAME: BASALOID CARCINOMA    
NAME: CLOACOGENIC CARCINOMA IN SITU    NAME: CLOACOGENIC CARCINOMA    NAME: PAPILLARY TRANS CELL NEOPLASM OF LOW MALIG    NAME: PAPILLARY TRANSITIONAL CELL CA, NON-INVASIVE    NAME: PAPILLARY TRANSITIONAL CELL CARCINOMA    NAME: TRANSITIONAL CELL CA IN SITU, MICROPAPILLARY    NAME: TRANSITIONAL CELL CARCINOMA, MICROPAPILLARY    NAME: ADENOMA, NOS    
NAME: ATYPICAL ADENOMA    NAME: ADENOCARCINOMA IN SITU, NOS    NAME: ADENOCARCINOMA, NOS    NAME: SCIRRHOUS ADENOCARCINOMA IN SITU    NAME: SCIRRHOUS ADENOCARCINOMA    NAME: LINITIS PLASTICA IN SITU    NAME: LINITIS PLASTICA    NAME: SUPERFICIAL SPREADING ADENOCARCINOMA IN SITU    
NAME: SUPERFICIAL SPREADING ADENOCARCINOMA    NAME: INTESTINAL-TYPE ADENOMA, HIGH GRADE (C16._,C17._) [REPORTABLE 2022+    NAME: ADENOCARCINOMA, INTESTINAL TYPE    NAME: CARCINOMA IN SITU, DIFFUSE TYPE    NAME: CARCINOMA, DIFFUSE TYPE    NAME: MONOMORPHIC ADENOMA    NAME: BASAL CELL ADENOMA    NAME: BASAL CELL ADENOCARCINOMA IN SITU    
NAME: BASAL CELL ADENOCARCINOMA    NAME: GLANDULAR INTRAEPITHELIAL NEOPLASIA, GR III    NAME: CANALICULAR ADENOMA    NAME: ISLET CELL ADENOMA    NAME: PACREATIC ENDOCRINE TUMOR, NOS (C25._)[PRE-2021 ONLY, FOR 2021+ 8150/3]    NAME: ISLET CELL CARCINOMA IN SITU    NAME: PANCREATIC ENDOCRINE TUMOR, NOS (C25.4)    NAME: INSULINOMA, NOS    
NAME: INSULINOMA IN SITU    NAME: INSULINOMA, NOS (C25.4)    NAME: GLUCAGONOMA, NOS    NAME: GLUCAGONOMA IN SITU    NAME: GLUCAGONOMA    NAME: GASTRINOMA, NOS    NAME: GASTRINOMA IN SITU    NAME: GASTRINOMA    
NAME: MIXED ISLET CELL AND EXOCRINE ADENOCA IN SITU    NAME: MIXED ISLET CELL AND EXOCRINE ADENOCARCINOMA    NAME: VIPOMA, NOS    NAME: VIPOMA IN SITU    NAME: VIPOMA    NAME: SOMATOSTATINOMA, NOS    NAME: SOMATOSTATINOMA IN SITU    NAME: SOMATOSTATINOMA    
NAME: ENTEROGLUCAGONOMA, NOS    NAME: ENTEROGLUCAGONOMA IN SITU    NAME: ENTEROGLUCAGONOMA, MALIGNANT    NAME: ACTH-PRODUCING TUMOR [2018-2020 ONLY, FOR 2021+ USE CODE 8158/3]    NAME: ACTH-PRODUCING TUMOR    NAME: BILE DUCT ADENOMA    NAME: CHOLANGIOCARCINOMA IN SITU    NAME: CHOLANGIOCARCINOMA    
NAME: BILE DUCT CYSTADENOMA    NAME: BILE DUCT CYSTADENOCARCINOMA IN SITU    NAME: BILE DUCT CYSTADENOCARCINOMA    NAME: KLATSKIN TUMOR IN SITU    NAME: KLATSKIN TUMOR    NAME: PAPILLARY NEOPLASM, PANCREATOBILIARY TYPE, WITH HIGH GRADE    NAME: PANCREATOBILIARY-TYPE CARCINOMA (C24.1)    NAME: LIVER CELL ADENOMA    
NAME: HEPATOCELLULAR CA IN SITU    NAME: HEPATOCELLULAR CARCINOMA, NOS    NAME: HEPATOCELLULAR CA IN SITU, FIBROLAMELLAR    NAME: HEPATOCELLULAR CARCINOMA, FIBROLAMELLAR    NAME: HEPATOCELLULAR CA IN SITU, SCIRRHOUS    NAME: HEPATOCELLULAR CARCINOMA, SCIRRHOUS    NAME: HEPATOCELLULAR CA IN SITU, SPINDLE CELL VAR    NAME: HEPATOCELLULAR CA, SPINDLE CELL VARIANT    
NAME: HEPATOCELLULAR CA IN SITU, CLEAR CELL TYPE    NAME: HEPATOCELLULAR CARCINOMA, CLEAR CELL TYPE    NAME: HEPATOCELLULAR CA IN SITU, PLEOMORPHIC TYPE    NAME: HEPATOCELLULAR CARCINOMA, PLEOMORPHIC TYPE    NAME: COMB HEPATOCELLULAR CA/CHOLANGIOCA IN SITU    NAME: COMB HEPATOCELLULAR CA AND CHOLANGIOCARCINOMA    NAME: TRABECULAR ADENOMA    NAME: TRABECULAR ADENOCARCINOMA IN SITU    
NAME: TRABECULAR ADENOCARCINOMA    NAME: EMBRYONAL ADENOMA    NAME: ECCRINE DERMAL CYLINDROMA    NAME: ADENOID CYSTIC CARCINOMA IN SITU    NAME: ADENOID CYSTIC CARCINOMA    NAME: CRIBRIFORM CARCINOMA IN SITU    NAME: CRIBRIFORM CARCINOMA, NOS    NAME: MICROCYSTIC ADENOMA    
NAME: LACTATING ADENOMA    NAME: ADENOMATOUS POLYP, NOS    NAME: ADENOCARCINOMA IN SITU IN ADENOMATOUS POLYP    NAME: ADENOCARCINOMA ADENOMATOUS IN POLYP    NAME: TUBULAR ADENOMA, NOS    NAME: TUBULAR ADENOCARCINOMA IN SITU    NAME: TUBULAR ADENOCARCINOMA    NAME: FLAT ADENOMA    
NAME: SERRATED ADENOMA    NAME: SERRATED DYSPLASIA HIGH GRADE (C16._ , C17._)    NAME: SERRATED ADENOCARCINOMA (C18.0, C18.2, C18.9, C19.9, C20.9)    NAME: PARIETAL CELL CARCINOMA IN SITU    NAME: PARIETAL CELL CARCINOMA    NAME: ADENOCARCINOMA OF ANAL GLANDS IN SITU    NAME: ADENOCARCINOMA OF ANAL GLANDS    NAME: ADENOMATOUS POLYPOSIS COLI    
NAME: ADENOCA IN SITU IN FAMILIAL POLYPOSIS COLI    NAME: ADENOCARCINOMA IN ADENOMATOUS POLYPOSIS COLI    NAME: MULTIPLE ADENOMATOUS POLYPS    NAME: ADENOCA IN SITU IN MULT ADENOMATOUS POLYPS    NAME: ADENOCARCINOMA IN MULTIPLE ADENOMATOUS POLYPS    NAME: DUCTAL CARCINOMA IN SITU, SOLID TYPE    NAME: SOLID CARCINOMA, NOS    NAME: CARCINOMA SIMPLEX IN SITU    
NAME: CARCINOMA SIMPLEX    NAME: CARCINOID TUMOR OF UNCERTAIN MALIG POTENTIAL    NAME: CARCINOID TUMOR IN SITU    NAME: CARCINOID TUMOR, NOS    NAME: ENTEROCHROMAFFIN CELL CARCINOID IN SITU    NAME: ENTEROCHROMAFFIN CELL CARCINOID    NAME: ENTEROCHROMAFFIN-LIKE CELL CARCINOID, NOS    NAME: ENTEROCHROMAFFIN-LIKE CELL TUMOR IN SITU    
NAME: ENTEROCHROMAFFIN-LIKE CELL TUMOR, MALIGNANT    NAME: GOBLET CELL CARCINOID IN SITU    NAME: GOBLET CELL ADENOCARCINOMA [2022+]    NAME: COMPOSITE CARCINOID IN SITU    NAME: COMPOSITE CARCINOID    NAME: TUBULAR CARCINOID    NAME: ADENOCARCINOID TUMOR IN SITU    NAME: ADENOCARCINOID TUMOR    
NAME: NEUROENDOCRINE CARCINOMA IN SITU    NAME: NEUROENDOCRINE CARCINOMA, NOS    NAME: MERKEL CELL CARCINOMA, IN SITU    NAME: MERKEL CELL CARCINOMA    NAME: APUDOMA    NAME: ATYPICAL CARCINOID TUMOR IN SITU    NAME: ATYPICAL CARCINOID TUMOR    NAME: PULMONARY ADENOMATOSIS    
NAME: ADENOCARCINOMA IN SITU, NON-MUCINOUS (C34._)    NAME: LEPIDIC ADENOCARCINOMA (C34._)    NAME: ALVEOLAR ADENOMA    NAME: ALVEOLAR ADENOCARCINOMA IN SITU    NAME: ALVEOLAR ADENOCARCINOMA    NAME: BRONCHIOLO-ALVEOLAR CA IN SITU, NON-MUCINOUS    NAME: BRONCHIOLO-ALVEOLAR CARCINOMA, NON-MUCINOUS    NAME: BRONCHIOLO-ALVEOLAR CA IN SITU, MUCINOUS    
NAME: INVASIVE MUCINOUS ADENOCARCINOMA (C34._)    NAME: BRONCHIOLO-ALVEOLAR CA IN SITU, MIXED    NAME: MIXED INVASIVE MUCINOUS AND NON-MUCINOUS ADENOCARCINOMA (C34._)    NAME: ADENOCARCINOMA WITH MIXED SUBTYPES IN SITU    NAME: ADENOCARCINOMA WITH MIXED SUBTYPES    NAME: MINIMALLY INVASIVE ADENOCARCINOMA, NON-MUCINOUS (C34._)    NAME: MINIMALLY INVASIVE ADENOCARCINOMA, MUCINOUS (C34._)    NAME: PAPILLARY ADENOMA, NOS    
NAME: PAPILLARY ADENOCARCINOMA IN SITU    NAME: PAPILLARY ADENOCARCINOMA, NOS    NAME: VILLOUS ADENOMA, NOS    NAME: ADENOCARCINOMA IN SITU IN VILLOUS ADENOMA    NAME: ADENOCARCINOMA IN VILLOUS ADENOMA    NAME: VILLOUS ADENOCARCINOMA IN SITU    NAME: VILLOUS ADENOCARCINOMA    NAME: TUBULOVILLOUS ADENOMA, NOS    
NAME: ADENOCA IN SITU IN TUBULOVILLOUS ADENOMA    NAME: ADENOCARCINOMA IN TUBULOVILLOUS ADENOMA    NAME: PAPILLOMATOSIS, GLANDULAR    NAME: MICROPAPILLARY CARCINOMA, NOS (C18._, C19.9, C20.9, C34._)    NAME: CHROMOPHOBE ADENOMA    NAME: CHROMOPHOBE CARCINOMA IN SITU    NAME: CHROMOPHOBE CARCINOMA    NAME: PROLACTINOMA    
NAME: PITUITARY ADENOMA, NOS    NAME: PITUITARY CARCINOMA IN SITU    NAME: PITUITARY CARCINOMA, NOS    NAME: PITUITARY BLASTOMA    NAME: ACIDOPHIL ADENOMA    NAME: ACIDOPHIL CARCINOMA IN SITU    NAME: ACIDOPHIL CARCINOMA    NAME: MIXED ACIDOPHIL-BASOPHIL ADENOMA    
NAME: MIXED ACIDOPHIL-BASOPHIL CARCINOMA IN SITU    NAME: MIXED ACIDOPHIL-BASOPHIL CARCINOMA    NAME: OXYPHILIC ADENOMA    NAME: OXYPHILIC ADENOCARCINOMA IN SITU    NAME: OXYPHILIC ADENOCARCINOMA    NAME: BASOPHIL ADENOMA    NAME: BASOPHIL CARCINOMA IN SITU    NAME: BASOPHIL CARCINOMA    
NAME: CLEAR CELL ADENOMA    NAME: CLEAR CELL ADENOCARCINOMA IN SITU    NAME: CLEAR CELL ADENOCARCINOMA, NOS    NAME: HYPERNEPHROID TUMOR    NAME: HEREDITARY LEIOMYOMATOSIS & RCC- ASSOCIATED RENAL CELL CARCINOMA (C64.9)    NAME: RENAL CELL CARCINOMA IN SITU    NAME: RENAL CELL CARCINOMA, NOS    NAME: CLEAR CELL ADENOFIBROMA    
NAME: CLEAR CELL ADENOFIBROMA OF BORDERLINE MALIG    NAME: CLEAR CELL ADENOCARCINOFIBROMA IN SITU    NAME: CLEAR CELL ADENOCARCINOFIBROMA    NAME: LIPID RICH CARCINOMA IN SITU    NAME: LIPID RICH CARCINOMA    NAME: GLYCOGEN-RICH CARCINOMA IN SITU    NAME: GLYCOGEN-RICH CARCINOMA    NAME: CYST-ASSOCIATED RENAL CELL CARCINOMA IN SITU    
NAME: CYST-ASSOCIATED RENAL CELL CARCINOMA    NAME: RENAL CELL CA IN SITU, CHROMOPHOBE TYPE    NAME: RENAL CELL CARCINOMA, CHROMOPHOBE TYPE    NAME: RENAL CELL CA IN SITU, SARCOMATOID    NAME: RENAL CELL CARCINOMA, SARCOMATOID    NAME: COLLECTING DUCT CARCINOMA IN SITU    NAME: COLLECTING DUCT CARCINOMA    NAME: GRANULAR CELL CARCINOMA IN SITU    
NAME: GRANULAR CELL CARCINOMA    NAME: CHIEF CELL ADENOMA    NAME: WATER-CLEAR CELL ADENOMA    NAME: WATER-CLEAR CELL ADENOCARCINOMA IN SITU    NAME: WATER-CLEAR CELL ADENOCARCINOMA    NAME: MIXED CELL ADENOMA    NAME: MIXED CELL ADENOCARCINOMA IN SITU    NAME: MIXED CELL ADENOCARCINOMA    
NAME: LIPOADENOMA    NAME: METANEPHRIC ADENOMA    NAME: FOLLICULAR ADENOMA    NAME: ATYPICAL FOLLICULAR ADENOMA    NAME: FOLLICULAR ADENOCARCINOMA IN SITU    NAME: FOLLICULAR ADENOCARCINOMA, NOS    NAME: FOLLICULAR ADENOCA IN SITU, WELL DIFF    NAME: FOLLICULAR ADENOCA, WELL DIFFERENTIATED    
NAME: FOLLICULAR ADENOCA IN SITU, TRABECULAR    NAME: FOLLICULAR ADENOCARCINOMA, TRABECULAR    NAME: MICROFOLLICULAR ADENOMA, NOS    NAME: FETAL ADENOCARCINOMA IN SITU    NAME: FETAL ADENOCARCINOMA    NAME: MACROFOLLICULAR ADENOMA    NAME: FOLLICULAR TUMOR OF UNCERTAIN MALIGNANT POTENTIAL (C73.0)    NAME: FOLLICULAR CARCINOMA IN SITU    
NAME: FOLLICULAR CARCINOMA, MINIMALLY INVASIVE    NAME: HYALINIZING TRABECULAR ADENOMA    NAME: HYALINIZING TRABECULAR ADENOMA    NAME: INSULAR CARCINOMA IN SITU    NAME: POORLY DIFFERENTIATED THYROID CARCINOMA (C73.9) {2021+]    NAME: FOLLICULAR THYROID CARCINOMA (FTC), ENCAPSULATED ANGOINVASIVE (C73.9)    NAME: PAPILLARY CA IN SITU, FOLLICULAR VARIANT    NAME: PAPILLARY CARCINOMA, FOLLICULAR VARIANT    
NAME: PAPILLARY MICROCARCINOMA IN SITU    NAME: PAPILLARY MICROCARCINOMA    NAME: PAPILLARY CARCINOMA IN SITU, OXYPHILIC CELL    NAME: PAPILLARY CARCINOMA, OXYPHILIC CELL    NAME: NON-INV FOLLICULAR THYROID NEOPLASM W/ PAPILLARY-LIKE NUCLEAR FEATURE    NAME: PAPILLARY CARCINOMA, ENCAPSULATED    NAME: PAPILLARY CARCINOMA IN SITU, COLUMNAR CELL    NAME: PAPILLARY CARCINOMA, COLUMNAR CELL    
NAME: MEDULLARY CARCINOMA W AMYLOID STROMA IN SITU    NAME: MEDULLARY CARCINOMA WITH AMYLOID STROMA    NAME: MIXED MEDULLARY-FOLLICULAR CARCINOMA IN SITU    NAME: MIXED MEDULLARY-FOLLICULAR CARCINOMA    NAME: MIXED MEDULLARY-PAPILLARY CARCINOMA IN SITU    NAME: MIXED MEDULLARY-PAPILLARY CARCINOMA    NAME: WELL DIFFERENTIATED TUMOR OF UNCERTAIN MALIGNANT POTENTIAL    NAME: NON-INVASIVE FOLLICULAR THYROID NEOPLASM W/PAPPILARY-LIKE FEATURES (C73.9)    
NAME: NONENCAPSULATED SCLEROSING CARCINOMA IN SITU    NAME: NONENCAPSULATED SCLEROSING CARCINOMA    NAME: MULTIPLE ENDOCRINE ADENOMAS    NAME: JUXTAGLOMERULAR TUMOR    NAME: ADRENAL CORTICAL ADENOMA, NOS    NAME: ADRENAL CORTICAL CARCINOMA IN SITU    NAME: ADRENAL CORTICAL CARCINOMA    NAME: ADRENAL CORTICAL ADENOMA, COMPACT CELL    
NAME: ADRENAL CORTICAL ADENOMA, PIGMENTED    NAME: ADRENAL CORTICAL ADENOMA, CLEAR CELL    NAME: ADRENAL CORTICAL ADENOMA, GLOMERULOSA CELL    NAME: ADRENAL CORTICAL ADENOMA, MIXED CELL    NAME: ENDOMETRIOID ADENOMA, NOS    NAME: ENDOMETRIOID ADENOMA, BORDERLINE MALIGNANCY    NAME: ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA (C54._)[2018+;REPORTABLE 2021+]    NAME: ENDOMETRIOID ADENOCARCINOMA, NOS    
NAME: ENDOMETRIOID ADENOFIBROMA, NOS    NAME: ENDOMETRIOID ADENOFIBROMA, BORDERLINE MALIG    NAME: ENDOMETRIOID ADENOFIBROMA IN SITU    NAME: ENDOMETRIOID ADENOFIBROMA, MALIGNANT    NAME: ENDOMETRIOID ADENOCA IN SITU, SECRETORY VAR    NAME: ENDOMETRIOID ADENOCA, SECRETORY VARIANT    NAME: ENDOMETRIOID ADENOCA IN SITU, CILIATED CELL    NAME: ENDOMETRIOID ADENOCA, CILIATED CELL VARIANT    
NAME: ADENOCARCINOMA IN SITU, ENDOCERVICAL TYPE    NAME: ADENOCARCINOMA, ENDOCERVICAL TYPE    NAME: SKIN APPENDAGE ADENOMA    NAME: SKIN APPENDAGE CARCINOMA IN SITU    NAME: SKIN APPENDAGE CARCINOMA    NAME: FOLLICULAR FIBROMA    NAME: SYRINGOFIBROADENOMA    NAME: SWEAT GLAND ADENOMA    
NAME: SWEAT GLAND TUMOR, NOS    NAME: SWEAT GLAND ADENOCARCINOMA IN SITU    NAME: SWEAT GLAND ADENOCARCINOMA    NAME: APOCRINE ADENOMA    NAME: APOCRINE ADENOCARCINOMA, IN SITU    NAME: APOCRINE ADENOCARCINOMA    NAME: NODULAR HIDRADENOMA    NAME: NODULAR HIDRADENOMA IN SITU    
NAME: NODULAR HIDRADENOMA, MALIGNANT    NAME: ECCRINE SPIRADENOMA    NAME: ECCRINE SPIRADENOMA IN SITU    NAME: MALIGNANT ECCRINE SPIRADENOMA    NAME: HIDROCYSTOMA    NAME: PAPILLARY HIDRADENOMA    NAME: PAPILLARY SYRINGADENOMA    NAME: PAPILLARY SYRINGADENOCARCINOMA IN SITU    
NAME: SYRINGOCYSTADENOCARCINOMA PAPILLIFERUM [2022+]    NAME: SYRINGOMA, NOS    NAME: SCLEROSING SWEAT DUCT CARCINOMA IN SITU    NAME: SCLEROSING SWEAT DUCT CARCINOMA    NAME: ECCRINE PAPILLARY ADENOMA    NAME: AGGRESSIVE DIGITAL PAPILLARY ADENOMA (PRE-2021 CASES)    NAME: ECCRINE PAPILLARY ADENOCARCINOMA IN SITU    NAME: AGGRESSIVE DIGITAL PAPILLARY ADENOMA (C44._)    
NAME: ECCRINE POROMA    NAME: POROCARCINOMA IN SITU [2022+]    NAME: ECCRINE POROMA, MALIGNANT    NAME: SEBACEOUS ADENOMA    NAME: SEBACEOUS ADENOCARCINOMA IN SITU    NAME: SEBACEOUS ADENOCARCINOMA    NAME: ECCRINE ADENOCARCINOMA IN SITU    NAME: ECCRINE ADENOCARCINOMA    
NAME: CERUMINOUS ADENOMA    NAME: CERUMINOUS ADENOCARCINOMA IN SITU    NAME: CERUMINOUS ADENOCARCINOMA    NAME: MUCOEPIDERMOID TUMOR    NAME: MUCOEPIDERMOID CARCINOMA IN SITU    NAME: MUCOEPIDERMOID CARCINOMA    NAME: CYSTADENOMA, NOS    NAME: SEROUS CYSTADENOMA OF UNC MALIGNANT POTENTIAL    
NAME: CYSTADENOCARCINOMA IN SITU    NAME: CYSTADENOCARCINOMA, NOS    NAME: SEROUS CYSTADENOMA, NOS    NAME: SEROUS CYSTADENOCARCINOMA IN SITU    NAME: SEROUS CYSTADENOCARCINOMA, NOS    NAME: SEROUS CYSTADENOMA, BORDERLINE    NAME: CLEAR CELL CYSTADENOMA    NAME: CLEAR CELL CYSTIC/BORDERLINE MALIGNANCY    
NAME: PAPILLARY CYSTADENOMA, NOS    NAME: PAPILLARY CYSTADENOCARCINOMA IN SITU    NAME: PAPILLARY CYSTADENOCARCINOMA, NOS    NAME: PAPILLARY CYSTADENOMA, BORDERLINE    NAME: SOLID PSEUDOPAPILLARY TUMOR (PRE-2021 CASES)    NAME: SOLID PSEUDOPAPILLARY CARCINOMA IN SITU    NAME: SOLID PSEUDOPAPILLARY NEOPLASM OF PANCREAS    NAME: INTRADUCTAL PAPILLARY-MUCINOUS ADENOMA    
NAME: INTRADUCTAL PAPILLARY-MUCINOUS/MOD DYSPLASIA    NAME: INTRADUCTAL PAPILLARY-MUCINOUS CA, NON-INV    NAME: INTRADUCTAL PAPILLARY-MUCINOUS CA, INVASIVE    NAME: CYSTIC TUMOR OF ATRIO-VENTRICULAR NODE    NAME: INTRADUCTAL ONCOCYTIC PAPILLARY NEOPLASM, NOS    NAME: INTRADUCTAL ONCOCYTIC PAPILLARY NEOPLASM WITH ASSOCIATED INVASIVE CARCINOMA    NAME: PAPILLARY SEROUS CYSTADENOMA, NOS    NAME: PAPILLARY SEROUS CYSTADENOCARCINOMA IN SITU    
NAME: PAPILLARY SEROUS CYSTADENOCARCINOMA    NAME: SEROUS SURFACE PAPILLOMA    NAME: SEROUS SURFACE PAPILLOMA OF UNC MALIGNANT POT    NAME: SEROUS SURFACE PAPILLARY CARCINOMA IN SITU    NAME: SEROUS SURFACE PAPILLARY CARCINOMA    NAME: SEROUS PAPILLARY CYSTIC TUMOR, BORDERLINE    NAME: SEROUS SURFACE PAPILLARY TUMOR/BORDERLINE MAL    NAME: MUCINOUS CYSTADENOMA, NOS    
NAME: MUCINOUS CYSTIC TUMOR WITH MODERATE DYSPLASIA    NAME: MUCINOUS CYSTADENOCARCINOMA, NON-INVASIVE    NAME: MUCINOUS CYSTADENOCARCINOMA, NOS    NAME: PAPILLARY MUCINOUS CYSTADENOMA, NOS    NAME: PAPILLARY MUCINOUS CYSTADENOCARCINOMA IN SITU    NAME: PAPILLARY MUCINOUS CYSTADENOCARCINOMA (C56.9)    NAME: MUCINOUS CYSTIC TUMOR, BORDERLINE    NAME: PAPILLARY MUCINOUS CYSTADENOMA, BORDERLINE    
NAME: SEROMUCINOUS CARCINOMA (C56.9)    NAME: MUCINOUS ADENOMA    NAME: LOW GRADE APPENDICEAL MUCINOUS NEOPLASM (C18.1)    NAME: HIGH GRADE APPENDICEAL MUCINOUS NEOPLASM (HAMN) (C181) [2022+]    NAME: MUCINOUS ADENOCARCINOMA    NAME: MUCIN-PRODUCING ADENOCARCINOMA IN SITU    NAME: MUCIN-PRODUCING ADENOCARCINOMA    NAME: MUCINOUS ADENOCA IN SITU, ENDOCERVICAL TYPE    
NAME: MUCINOUS ADENOCARCINOMA, ENDOCERVICAL TYPE    NAME: ADENOCARCINOMA IN SITU, HPV-ASSOCIATED    NAME: ADENOCARCINOMA HPV-ASSOCIATED    NAME: ADENOCARCINOMA IN SITU HPV-INDEPENDENT    NAME: ADENOCARCINOMA HPV-INDEPENDENT NOS    NAME: SIGNET RING CELL CARCINOMA IN SITU    NAME: SIGNET RING CELL CARCINOMA    NAME: DUCTAL CARCINOMA, NONINFILTRATING, NOS    
NAME: INFILTRATING DUCT CARCINOMA, NOS    NAME: COMEDOCARCINOMA, NONINFILTRATING    NAME: COMEDOCARCINOMA, NOS    NAME: JUVENILE CARCINOMA, IN SITU, OF BREAST    NAME: SECRETORY CARCINOMA OF BREAST    NAME: INTRADUCTAL PAPILLOMA    NAME: NONINFILTRATING INTRADUCTAL PAPILLARY ADENOCA    NAME: INTRADUCTAL PAPILLARY ADENOCA WITH INVASION    
NAME: INTRACYSTIC PAPILLARY ADENOMA    NAME: NONINFILTRATING INTRACYSTIC CARCINOMA    NAME: INTRACYSTIC CARCINOMA, NOS    NAME: INTRADUCTAL PAPILLOMATOSIS, NOS    NAME: ADENOMA OF NIPPLE    NAME: INTRADUCTAL MICROPAPILLARY CARCINOMA    NAME: INVASIVE MICROPAPILLARY CARCINOMA (C50._)    NAME: CYSTIC HYPERSECRETORY CARCINOMA IN SITU    
NAME: CYSTIC HYPERSECRETORY CARCINOMA    NAME: SOLID PAPILLARY CARCINOMA IN SITU (C50._)    NAME: TALL CELL CARCINOMA WITH REVERSED POLARITY [2022+]    NAME: MEDULLARY CARCINOMA IN SITU    NAME: MEDULLARY CARCINOMA, NOS    NAME: MEDULLARY CARCINOMA W LYMPHOID STROMA IN SITU    NAME: MEDULLARY CARCINOMA WITH LYMPHOID STROMA    NAME: ATYPICAL MEDULLARY CARCINOMA IN SITU    
NAME: ATYPICAL MEDULLARY CARCINOMA    NAME: DUCT CARCINOMA IN SITU, DESMOPLASTIC TYPE    NAME: DUCT CARCINOMA, DESMOPLASTIC TYPE    NAME: PLEOMORPHIC LOBULAR CARCINOMA IN SITU (C50._)    NAME: LOBULAR CARCINOMA IN SITU, NOS    NAME: LOBULAR CARCINOMA, NOS    NAME: INFILTRATING DUCTULAR CARCINOMA IN SITU    NAME: INFILTRATING DUCTULAR CARCINOMA    
NAME: INFILTRATING DUCT AND LOBULAR CA IN SITU    NAME: INFILTRATING DUCT AND LOBULAR CARCINOMA    NAME: INFILTRATING DUCT IN SITU W OTHER TYPES OF CA    NAME: INFILTRATING DUCT MIXED W OTHER TYPES OF CA    NAME: IN SITU LOBULAR MIXED WITH OTHER IN SITU CA    NAME: INFILTRATING LOBULAR MIXED W OTHER TYPES CA    NAME: POLYMORPHOUS LOW GRADE ADENOCARCINOMA IN SITU    NAME: POLYMORPHOUS LOW GRADE ADENOCARCINOMA    
NAME: INFLAMMATORY CARCINOMA IN SITU    NAME: INFLAMMATORY CARCINOMA    NAME: PAGET DISEASE, MAMMARY, IN SITU    NAME: PAGET DISEASE, MAMMARY    NAME: PAGET DISEASE/INFLT DUCT CA OF BREAST IN SITU    NAME: PAGET DISEASE/INFILTRATING DUCT CA OF BREAST    NAME: PAGET DISEASE, EXTRAMAMMARY, IN SITU    NAME: PAGET DISEASE, EXTRAMAMMARY    
NAME: PAGET DISEASE/INTRADUCT CA OF BREAST IN SITU    NAME: PAGET DISEASE AND INTRADUCTAL CA OF BREAST    NAME: ACINAR CELL ADENOMA    NAME: ACINAR CELL TUMOR    NAME: ACINAR CELL CARCINOMA IN SITU    NAME: ACINAR CELL CARCINOMA    NAME: ACINAR CELL CYSTADENOCARCINOMA IN SITU    NAME: ACINAR CELL CYSTADENOCARCINOMA    
NAME: MIXED ACINAR DUCTAL CARCINOMA    NAME: MIXED SQUAMOUS CELL AND GLANDULAR PAPILLOMA    NAME: ADENOSQUAMOUS CARCINOMA IN SITU    NAME: ADENOSQUAMOUS CARCINOMA    NAME: ADENOLYMPHOMA    NAME: EPITHELIAL-MYOPITHELIAL CARCINOMA IN SITU    NAME: EPITHELIAL-MYOPITHELIAL CARCINOMA    NAME: LYMPHADENOMA    
NAME: ADENOCARCINOMA W SQUAMOUS METAPLASIA IN SITU    NAME: ADENOCARCINOMA WITH SQUAMOUS METAPLASIA    NAME: ADENOCA W CARTILAG & OSSEOUS METAPLAS IN SITU    NAME: ADENOCA W CARTILAGINOUS & OSSEOUS METAPLASIA    NAME: ADENOCA W SPINDLE CELL METAPLASIA IN SITU    NAME: ADENOCARCINOMA WITH SPINDLE CELL METAPLASIA    NAME: ADENOCA W APOCRINE METAPLASIA IN SITU    NAME: ADENOCARCINOMA WITH APOCRINE METAPLASIA    
NAME: ADENOCA W NEUROENDOCRINE DIFF IN SITU    NAME: ADENOCA WITH NEUROENDOCRINE DIFFERENTIATION    NAME: METAPLASTIC CARCINOMA IN SITU    NAME: METAPLASTIC CARCINOMA, NOS    NAME: HEPATOID ADENOCARCINOMA IN SITU    NAME: HEPATOID ADENOCARCINOMA    NAME: THYMOMA, BENIGN    NAME: THYMOMA, NOS    
NAME: THYMOMA, IN SITU    NAME: THYMOMA, NOS (C37.9)    NAME: THYMOMA, TYPE A, NOS    NAME: THYMOMA, TYPE A, IN SITU    NAME: TYPE A THYMOMA INCLUDING ATYPICAL VARIANT (C37.9)    NAME: THYMOMA, TYPE AB, NOS    NAME: THYMOMA, TYPE AB, IN SITU    NAME: TYPE AB THYMOMA (C37.9)    
NAME: THYMOMA, TYPE B1, NOS    NAME: THYMOMA, TYPE B1, IN SITU    NAME: TYPE B1 THYMOMA (C37.9)    NAME: THYMOMA, TYPE B2, NOS    NAME: THYMOMA, TYPE B2, IN SITU    NAME: TYPE B2 THYMOMA (C37.9)    NAME: THYMOMA, TYPE B3, NOS    NAME: THYMOMA, TYPE B3, IN SITU    
NAME: TYPE B3 THYMOMA (C37.9)    NAME: THYMIC CARCINOMA IN SITU    NAME: THYMIC CARCINOMA, NOS    NAME: ECTOPIC HAMARTOMATOUS THYMOMA    NAME: SPINDLE EPITHELIAL TUM W THYMUS ELEM IN SITU    NAME: SPINDLE EPITHELIAL TUMOR W THYMUS-LIKE ELEM    NAME: CARCINOMA SHOWING THYMUS-LIKE ELEMENT IN SITU    NAME: INTRATHYROID THYMIC CARCINOMA (C73.9) [2021+]    
NAME: SEX CORD-GONADAL STROMAL TUMOR    NAME: SEX CORD-GONADAL STROMAL TUMOR, INC DIFF    NAME: SEX CORD-GONADAL STROMAL TUMOR, MIXED FORMS    NAME: STROMAL TUMOR WITH MINOR SEX CORD ELEMENTS    NAME: MIXED GERM CELL SEX CORD-STROMAL TUMOR, UNCLASSIFIED (C48.2, C56.9, C57.9)    NAME: THECOMA, NOS    NAME: THECOMA IN SITU    NAME: THECOMA, MALIGNANT    
NAME: THECOMA, LUTEINIZED    NAME: SCLEROSING STROMAL TUMOR    NAME: LUTEOMA, NOS    NAME: GRANULOSA CELL TUMOR, ADULT TYPE    NAME: GRANULOSA CELL TUMOR IN SITU    NAME: GRANULOSA CELL TUMOR, ADULT TYPE (C56.9)    NAME: GRANULOSA CELL-THECA CELL TUMOR    NAME: GRANULOSA CELL-THECA CELL TUMOR IN SITU    
NAME: GRANULOSA CELL-THECA CELL TUMOR, MALIGNANT    NAME: GRANULOSA CELL TUMOR, JUVENILE    NAME: JUVENILE GRANULOSA CELL TUMOR IN SITU    NAME: JUVENILE GRANULOSA CELL TUMOR, MALIGNANT    NAME: SEX CORD TUMOR WITH ANNULAR TUBULES    NAME: ANDROBLASTOMA, BENIGN    NAME: ANDROBLASTOMA, NOS    NAME: ANDROBLASTOMA IN SITU    
NAME: ANDROBLASTOMA, MALIGNANT    NAME: SERTOLI-LEYDIG CELL TUMOR, WELL DIFF    NAME: SERTOLI-LEYDIG CELL TUMOR, INTERMEDIATE DIFF    NAME: SERTOLI-LEYDIG CELL TUMOR IN SITU, POOR DIFF    NAME: SERTOLI-LEYDIG CELL TUMOR, POORLY DIFF    NAME: GYNANDROBLASTOMA    NAME: TUBULAR ANDROBLASTOMA IN SITU    NAME: TUBULAR ANDROBLASTOMA, MALIGNANT    
NAME: SERTOLI-LEYDIG CELL TUMOR, RETIFORM    NAME: SERTOLI-LEYDIG CELL TUMOR, INT DIFF, HET ELEM    NAME: SERTOLI-LEYDIG CELL TUMOR IN SITU, HET ELEM    NAME: SERTOLI-LEYDIG CELL TUMOR, POOR DIFF, HET ELE    NAME: SERTOLI CELL TUMOR, NOS    NAME: SERTOLI CELL CARCINOMA IN SITU    NAME: SERTOLI CELL CARCINOMA    NAME: SERTOLI CELL TUMOR WITH LIPID STORAGE    
NAME: LARGE CELL CALCIFYING SERTOLI CELL TUMOR    NAME: INTRATUBULAR LARGE CELL HYALINIZING SERTOLI CELL NEOPLASIA    NAME: LEYDIG CELL TUMOR, BENIGN    NAME: LEYDIG CELL TUMOR, NOS    NAME: LEYDIG CELL TUMOR IN SITU    NAME: LEYDIG CELL TUMOR, MALIGNANT    NAME: HILUS CELL TUMOR    NAME: LIPID CELL TUMOR OF OVARY    
NAME: STEROID CELL TUMOR IN SITU    NAME: STEROID CELL TUMOR, MALIGNANT    NAME: ADRENAL REST TUMOR    NAME: PARAGANGLIOMA, BENIGN    NAME: PARAGANGLIOMA, NOS    NAME: PARAGANGLIOMA IN SITU    NAME: PARAGANGLIOMA, MALIGNANT    NAME: SYMPATHETIC PARAGANGLIOMA    
NAME: SYMPATHETIC PARAGANGLIOMA    NAME: PARASYMPATHETIC PARAGANGLIOMA    NAME: PARASYMPATHETIC PARAGANGLIOMA    NAME: GANGLIOCYTIC PARAGANGLIOMA    NAME: GLOMUS JUGULARE TUMOR, NOS    NAME: MIDDLE EAR PARAGANGLIOMA (C30.1, C75.5)    NAME: AORTIC BODY TUMOR (PRE-2021 CASES)    NAME: AORTIC BODY TUMOR IN SITU    
NAME: AORTIC BODY TUMOR (C75.5)    NAME: CAROTID BODY TUMOR    NAME: CAROTID BODY TUMOR IN SITU    NAME: CAROTID BODY PARAGANGLIOMA (C75.4)    NAME: EXTRA-ADRENAL PARAGANGLIOMA, NOS (PRE-2021 CASES)    NAME: EXTRA-ADRENAL PARAGANGLIOMA IN SITU    NAME: EXTRA-ADRENAL PARAGANGLIOMA, NOS    NAME: PHEOCHROMOCYTOMA, NOS (PRE-2021 CASES)    
NAME: PHEOCHROMOCYTOMA IN SITU    NAME: PHEOCHROMOCYTOMA, NOS (C74.1)    NAME: GLOMANGIOSARCOMA IN SITU    NAME: GLOMANGIOSARCOMA    NAME: GLOMUS TUMOR, NOS    NAME: GLOMUS TUMOR IN SITU    NAME: GLOMUS TUMOR, MALIGNANT    NAME: GLOMANGIOMA    
NAME: GLOMANGIOMYOMA    NAME: PECOMA, MALIGNANT    NAME: PIGMENTED NEVUS, NOS    NAME: MELANOMA IN SITU    NAME: MALIGNANT MELANOMA, NOS    NAME: NODULAR MELANOMA, IN SITU    NAME: NODULAR MELANOMA    NAME: BALLOON CELL NEVUS    
NAME: BALLOON CELL MELANOMA, IN SITU    NAME: BALLOON CELL MELANOMA    NAME: HALO NEVUS    NAME: MELANOMA IN SITU, REGRESSING    NAME: MALIGNANT MELANOMA, REGRESSING    NAME: NEURONEVUS    NAME: MAGNOCELLULAR NEVUS    NAME: MELANOCYTOMA OF UNCERTAIN MALIGNANT POTENTIAL    
NAME: MAGNOCELLULAR MELANOMA IN SITU    NAME: MAGNOCELLULAR MELANOMA    NAME: DYSPLASTIC NEVUS    NAME: DIFFUSE MELANOCYTOSIS    NAME: MENINGEAL MELANOCYTOMA    NAME: MENINGEAL MELANOMATOSIS IN SITU    NAME: MENINGEAL MELANOMATOSIS    NAME: NONPIGMENTED NEVUS    
NAME: AMELANOTIC MELANOMA, IN SITU    NAME: AMELANOTIC MELANOMA    NAME: JUNCTIONAL NEVUS, NOS    NAME: MALIGNANT MELANOMA IN SITU/JUNCTIONAL NEVUS    NAME: MALIGNANT MELANOMA IN JUNCTIONAL NEVUS    NAME: PRECANCEROUS MELANOSIS, NOS    NAME: MALIGNANT MELANOMA IN PRECANCEROUS MELANOSIS    NAME: LENTIGINOUS MELANOCYTIC NEVUS    
NAME: LENTIGO MALIGNA    NAME: LENTIGO MALIGNA MELANOMA    NAME: SUPERFICIAL SPREADING MELANOMA, IN SITU    NAME: LOW CUMULATIVE SUN DAMAGED MELANOMA (C44._) [2021+]    NAME: ACRAL LENTIGINOUS MELANOMA, IN SITU    NAME: ACRAL LENTIGINOUS MELANOMA, MALIGNANT    NAME: DESMOPLASTIC MELANOMA IN SITU    NAME: DESMOPLASTIC MELANOMA, MALIGNANT    
NAME: MUCOSAL LENTIGINOUS MELANOMA IN SITU    NAME: MUCOSAL LENTIGINOUS MELANOMA    NAME: INTRADERMAL NEVUS    NAME: COMPOUND NEVUS    NAME: SMALL CONGENITAL NEVUS    NAME: GIANT PIGMENTED NEVUS, NOS    NAME: MELANOMA IN SITU IN GIANT PIGMENTED NEVUS    NAME: MALIGNANT MELANOMA IN GIANT PIGMENTED NEVUS    
NAME: PROLIFERATIVE DERMAL LESION CONGENITAL NEVUS    NAME: EPITHELIOID AND SPINDLE CELL NEVUS    NAME: MIXED EPITHELIOID/SPINDLE CELL MELA IN SITU    NAME: MIXED EPITHELIOID AND SPINDLE CELL MELANOMA    NAME: EPITHELIOID CELL NEVUS    NAME: EPITHELIOID CELL MELANOMA IN SITU    NAME: EPITHELIOID CELL MELANOMA    NAME: SPINDLE CELL NEVUS, NOS    
NAME: SPINDLE CELL MELANOMA IN SITU    NAME: SPINDLE CELL MELANOMA, NOS    NAME: SPINDLE CELL MELANOMA IN SITU, TYPE A    NAME: SPINDLE CELL MELANOMA, TYPE A    NAME: SPINDLE CELL MELANOMA IN SITU, TYPE B    NAME: SPINDLE CELL MELANOMA, TYPE B    NAME: BLUE NEVUS, NOS    NAME: BLUE NEVUS IN SITU    
NAME: BLUE NEVUS, MALIGNANT    NAME: CELLULAR BLUE NEVUS    NAME: SOFT TISSUE TUMOR, BENIGN    NAME: SARCOMA IN SITU    NAME: SARCOMA, NOS    NAME: SPINDLE CELL SARCOMA IN SITU    NAME: SPINDLE CELL SARCOMA    NAME: GIANT CELL SARCOMA IN SITU    
NAME: GIANT CELL SARCOMA    NAME: SMALL CELL SARCOMA IN SITU    NAME: SMALL CELL SARCOMA    NAME: EPITHELIOID SARCOMA IN SITU    NAME: EPITHELIOID SARCOMA    NAME: UNDIFFERENTIATED SARCOMA INS SITU    NAME: UNDIFFERENTIATED SARCOMA    NAME: DESMOPLASTIC SMALL ROUND CELL TUMOR IN SITU    
NAME: DESMOPLASTIC SMALL ROUND CELL TUMOR    NAME: FIBROMA, NOS    NAME: CELLULAR FIBROMA    NAME: FIBROSARCOMA IN SITU    NAME: FIBROSARCOMA, NOS    NAME: FIBROMYXOMA    NAME: MYXOINFLAMMATORY FIBROBLASTIC SARCOMA (mifs) (C49._)    NAME: FIBROMYXOSARCOMA IN SITU    
NAME: FIBROMYXOSARCOMA    NAME: PERIOSTEAL FIBROMA    NAME: PERIOSTEAL FIBROSARCOMA IN SITU    NAME: PERIOSTEAL FIBROSARCOMA    NAME: FASCIAL FIBROMA    NAME: FASCIAL FIBROSARCOMA IN SITU    NAME: FASCIAL FIBROSARCOMA    NAME: INFANTILE FIBROSARCOMA IN SITU    
NAME: INFANTILE FIBROSARCOMA    NAME: SOLITARY FIBROUS TUMOR    NAME: SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA GRADE 2 (CNS) (C71._)    NAME: SOLITARY FIBROUS TUMOR IN SITU    NAME: SOLITARY FIBROUS TUMOR, MALIGNANT    NAME: CALCIFYING APONEUROTIC FIBROMA    NAME: CALCIYING FIBROUS TUMOR    NAME: FIBROUS DYSPLASIA    
NAME: ELASTOFIBROMA    NAME: AGGRESSIVE FIBROMATOSIS    NAME: AGGRESSIVE FIBROMATOSIS IN SITU    NAME: AGGRESSIVE FIBROMATOSIS, MALIGNANT    NAME: ABDOMINAL FIBROMATOSIS    NAME: DESMOPLASTIC FIBROMA    NAME: MYOFIBROMA    NAME: MYOFIBROMATOSIS    
NAME: MYOFIBROBLASTOMA    NAME: MYOFIBROBLASTIC TUMOR, NOS    NAME: MYOFIBROBLASTIC SARCOMA    NAME: ANGIOMYOFIBROBLASTOMA    NAME: MYOFIBROBLASTIC TUMOR, PERIBRONCHIAL    NAME: NODULAR FASCIITIS    NAME: BENIGN FIBROUS HISTIOCYTOMA    NAME: ATYPICAL FIBROUS HISTIOCYTOMA    
NAME: FIBROUS HISTIOCYTOMA IN SITU    NAME: MALIGNANT FIBROUS HISTIOCYTOMA    NAME: HISTIOCYTOMA, NOS    NAME: DERMATOFIBROMA, NOS    NAME: DERMATOFIBROSARCOMA PROTUBERANS, NOS (C44._) [2021+, NOT REPORTABLE FOR PRE-2021    NAME: DERMATOFIBROSARCOMA IN SITU    NAME: DERMATOFIBROSARCOMA, NOS (PRE-2021 CASES)    NAME: PIGMENTED DERMATOFIBROSARCOMA PROTUBERANS (C44._)    
NAME: PIGMENTED DERMATOFIBROSARCOMA PROTUBE IN SITU    NAME: PIGMENTED DERMATOFIBROSARCOMA PROTUBERANS (PRE-2021 CASES)    NAME: GIANT CELL FIBROBLASTOMA    NAME: PLEXIFORM FIBROHISTIOCYTIC TUMOR    NAME: ANGIOMATOID FIBROUS HISTIOCYTOMA    NAME: MYXOMA, NOS    NAME: MYXOSARCOMA IN SITU    NAME: MYXOSARCOMA    
NAME: ANGIOMYXOMA    NAME: ANGIOMYXOMA    NAME: OSSIFYING FIBROMYXOID TUMOR    NAME: PULMONARY MYXOID SARCOMA WITH EWSR1-CREB1 TRANSLOCATION (C34._)    NAME: LIPOMA, NOS    NAME: ATYPICAL LIPOMA    NAME: LIPOSARCOMA IN SITU    NAME: LIPOSARCOMA, NOS    
NAME: FIBROLIPOMA    NAME: LIPOSARCOMA IN SITU, WELL DIFFERENTIATED    NAME: LIPOSARCOMA, WELL DIFFERENTIATED    NAME: FIBROMYXOLIPOMA    NAME: MYXOID LIPOSARCOMA IN SITU    NAME: MYXOID LIPOSARCOMA    NAME: ROUND CELL LIPOSARCOMA IN SITU    NAME: ROUND CELL LIPOSARCOMA    
NAME: PLEOMORPHIC LIPOMA    NAME: LIPOSARCOMA IN SITU, PLEOMORPHIC    NAME: LIPOSARCOMA, PLEOMORPHIC    NAME: MIXED LIPOSARCOMA IN SITU    NAME: MIXED LIPOSARCOMA    NAME: INTRAMUSCULAR LIPOMA    NAME: SPINDLE CELL LIPOMA    NAME: FIBROBLASTIC LIPOSARCOMA IN SITU    
NAME: FIBROBLASTIC LIPOSARCOMA    NAME: DEDIFFERENTIATED LIPOSARCOMA IN SITU    NAME: DEDIFFERENTIATED LIPOSARCOMA    NAME: MYXOID PLEOMORPHIC LIPOSARCOMA    NAME: ANGIOMYOLIPOMA    NAME: ANGIOMYOLIPOSARCOMA IN SITU    NAME: ANGIOMYOLIPOSARCOMA    NAME: ANGIOLIPOMA, NOS    
NAME: CHONDROID LIPOMA    NAME: MYELOLIPOMA    NAME: HIBERNOMA    NAME: LIPOBLASTOMATOSIS    NAME: NA    NAME: LEIOMYOMA, NOS    NAME: LEIOMYOMATOSIS, NOS    NAME: LEIOMYOSARCOMA IN SITU    
NAME: LEIOMYOSARCOMA, NOS    NAME: EPITHELIOID LEIOMYOMA    NAME: EPITHELIOID LEIOMYOSARCOMA IN SITU    NAME: EPITHELIOID LEIOMYOSARCOMA    NAME: CELLULAR LEIOMYOMA    NAME: BIZARRE LEIOMYOMA    NAME: ANGIOMYOMA    NAME: ANGIOMYOSARCOMA IN SITU    
NAME: ANGIOMYOSARCOMA    NAME: MYOMA    NAME: MYOSARCOMA IN SITU    NAME: MYOSARCOMA    NAME: MYXOID LEIOMYOSARCOMA IN SITU    NAME: MYXOID LEIOMYOSARCOMA    NAME: SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIG POTENT    NAME: METASTASIZING LEIOMYOMA    
NAME: RHABDOMYOMA, NOS    NAME: RHABDOMYOSARCOMA IN SITU    NAME: RHABDOMYOSARCOMA, NOS    NAME: PLEOMORPHIC RHABDOMYOSARCOMA IN SITU, ADULT    NAME: PLEOMORPHIC RHABDOMYOSARCOMA, ADULT TYPE    NAME: MIXED TYPE RHABDOMYOSARCOMA IN SITU    NAME: MIXED TYPE RHABDOMYOSARCOMA    NAME: FETAL RHABDOMYOMA    
NAME: ADULT RHABDOMYOMA    NAME: GENITAL RHABDOMYOMA    NAME: EMBRYONAL RHABDOMYOSARCOMA IN SITU    NAME: EMBRYONAL RHABDOMYOSARCOMA, NOS    NAME: SPINDLE CELL RHABDOMYOSARCOMA IN SITU    NAME: SPINDLE CELL RHABDOMYOSARCOMA    NAME: ALVEOLAR RHABDOMYOSARCOMA IN SITU    NAME: ALVEOLAR RHABDOMYOSARCOMA    
NAME: RHABDOMYOSARCOMA W GANGLIONIC DIFF IN SITU    NAME: RHABDOMYOSARCOMA W GANGLIONIC DIFFERENTIATION    NAME: ENDOMETRIAL STROMAL NODULE    NAME: ENDOMETRIAL STROMAL SARCOMA IN SITU    NAME: ENDOMETRIAL STROMAL SARCOMA, NOS    NAME: ENDOMETRIAL STROMAL SARCOMA IN SITU, LOW GRD    NAME: ENDOMETRIAL STROMAL SARCOMA, LOW GRADE    NAME: ADENOMYOMA    
NAME: ADENOSARCOMA IN SITU    NAME: ADENOSARCOMA    NAME: CARCINOFIBROMA IN SITU    NAME: CARCINOFIBROMA    NAME: STROMAL TUMOR, BENIGN    NAME: STROMAL TUMOR, NOS    NAME: STROMAL SARCOMA IN SITU    NAME: STROMAL SARCOMA, NOS    
NAME: GASTROINTESTINAL STROMAL TUMOR, BENIGN    NAME: GASTROINTESTINAL STROMAL TUMOR, NOS    NAME: GASTROINTESTINAL STROMAL SARCOMA IN SITU    NAME: GASTROINTESTINAL AUTONOMIC NERVE TUMOR    NAME: PLEOMORPHIC ADENOMA    NAME: MIXED TUMOR, IN SITU    NAME: MIXED TUMOR, MALIGNANT, NOS    NAME: CARCINOMA IN PLEOMORPHIC ADENOMA IN SITU    
NAME: CARCINOMA IN PLEOMORPHIC ADENOMA    NAME: MULLERIAN MIXED TUMOR IN SITU    NAME: MULLERIAN MIXED TUMOR    NAME: MESODERMAL MIXED TUMOR IN SITU    NAME: MESODERMAL MIXED TUMOR    NAME: BENIGN CYSTIC NEPHROMA    NAME: CYSTIC PARTIALLY DIFF NEPHROBLASTOMA    NAME: CYSTIC NEPHROMA IN SITU    
NAME: MALIGNANT CYSTIC NEPHROMA    NAME: MESOBLASTIC NEPHROMA    NAME: NEPHROBLASTOMA IN SITU    NAME: NEPHROBLASTOMA, NOS    NAME: RHABDOID TUMOR IN SITU    NAME: MALIGNANT RHABDOID TUMOR    NAME: CLEAR CELL SARCOMA OF KIDNEY IN SITU    NAME: CLEAR CELL SARCOMA OF KIDNEY    
NAME: NEPHROGENIC ADENOFIBROMA    NAME: RENOMEDULLARY INTERSTITIAL CELL TUMOR    NAME: OSSIFYING RENAL TUMOR    NAME: HEPATOBLASTOMA IN SITU    NAME: HEPATOBLASTOMA    NAME: PANCREATOBLASTOMA IN SITU    NAME: PANCREATOBLASTOMA    NAME: PULMONARY BLASTOMA IN SITU    
NAME: PULMONARY BLASTOMA    NAME: PLEUROPULMONARY BLASTOMA IN SITU    NAME: PLEUROPULMONARY BLASTOMA    NAME: SIALOBLASTOMA    NAME: CALCIFYING NESTED EPITHELIAL STROMAL TUMOR (C22.0)    NAME: GASTROBLASTOMA    NAME: CARCINOSARCOMA IN SITU    NAME: CARCINOSARCOMA, NOS    
NAME: CARCINOSARCOMA IN SITU, EMBRYONAL    NAME: CARCINOSARCOMA, EMBRYONAL    NAME: MYOEPITHELIOMA    NAME: MYOEPITHELIOMA IN SITU    NAME: MALIGNANT MYOEPITHELIOMA    NAME: ADENOMYOEPITHELIOMA    NAME: ADENOMYOEPITHELIOMA WITH CARCINOMA (C50._)    NAME: MESENCHYMOMA, BENIGN    
NAME: MESENCHYMOMA, NOS    NAME: MESENCHYMOMA IN SITU    NAME: MESENCHYMOMA, MALIGNANT    NAME: EMBRYONAL SARCOMA IN SITU    NAME: EMBRYONAL SARCOMA    NAME: PULMONARY HAMARTOMA    NAME: BRENNER TUMOR, NOS    NAME: BRENNER TUMOR, BORDERLINE MALIGNANCY    
NAME: BRENNER TUMOR IN SITU    NAME: BRENNER TUMOR, MALIGNANT    NAME: FIBROADENOMA, NOS    NAME: INTRACANALICULAR FIBROADENOMA    NAME: PERICANALICULAR FIBROADENOMA    NAME: ADENOFIBROMA, NOS    NAME: ADENOFIBROMA IN SITU    NAME: ADENOFIBROMA, MALIGNANT    
For the entire list of entries see: Here

External References

Name Field # of Occurrence
^DIC 43+1, 43.01+1, 43.02+1, 53+1, 53.01+1, 53.02+1

Global Variables Directly Accessed

Name Line Occurrences  (* Changed,  ! Killed)
^ONCO(169.3 - [#169.3] .01(XREF 1S), .01(XREF 1K), 1(XREF 1S), 1(XREF 1K), 4(XREF 1S), 4(XREF 1K), 4.1(XREF 1S), 4.1(XREF 1K)

Local Variables

Legend:

>> Not killed explicitly
* Changed
! Killed
~ Newed

Name Field # of Occurrence
>> DA .01(XREF 1S), .01(XREF 1K), 1(XREF 1S), 1(XREF 1K), 4(XREF 1S), 4(XREF 1K), 4.1(XREF 1S), 4.1(XREF 1K)
DIC 43+1!*, 43.01+1!*, 43.02+1!*, 53+1!*, 53.01+1!*, 53.02+1!*
DIC("S" 43+1*, 43SCR+1*, 43.01+1*, 43.01SCR+1*, 43.02+1*, 43.02SCR+1*, 53+1*, 53SCR+1*, 53.01+1*, 53.01SCR+1*
, 53.02+1*, 53.02SCR+1*
>> DIE 43+1, 43.01+1, 43.02+1, 53+1, 53.01+1, 53.02+1
X .001+1!, .01+1!, .01(XREF 1S), .01(XREF 1K), 1+1!, 1(XREF 1S), 1(XREF 1K), 4(XREF 1S), 4(XREF 1K), 4.1(XREF 1S)
4.1(XREF 1K), 43+1*!, 43.01+1*!, 43.02+1*!, 53+1*!, 53.01+1*!, 53.02+1*!
>> Y 43+1, 43.01+1, 43.02+1, 53+1, 53.01+1, 53.02+1
Info |  Desc |  Directly Accessed By Routines |  Accessed By FileMan Db Calls |  Pointed To By FileMan Files |  Pointer To FileMan Files |  Fields |  Found Entries |  External References |  Global Variables Directly Accessed |  Local Variables  | All